These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9827240)

  • 1. Rash in adult and pediatric patients treated with lamotrigine.
    Messenheimer JA
    Can J Neurol Sci; 1998 Nov; 25(4):S14-8. PubMed ID: 9827240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine-associated rash: risk/benefit considerations in adults and children.
    Guberman AH; Besag FM; Brodie MJ; Dooley JM; Duchowny MS; Pellock JM; Richens A; Stern RS; Trevathan E
    Epilepsia; 1999 Jul; 40(7):985-91. PubMed ID: 10403224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.
    Calabrese JR; Sullivan JR; Bowden CL; Suppes T; Goldberg JF; Sachs GS; Shelton MD; Goodwin FK; Frye MA; Kusumakar V
    J Clin Psychiatry; 2002 Nov; 63(11):1012-9. PubMed ID: 12444815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine and rash: scratching beneath the surface.
    Labiner DM
    J Clin Psychiatry; 2002 Nov; 63(11):1010-1. PubMed ID: 12469685
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk.
    Li LM; Russo M; O'Donoghue MF; Duncan JS; Sander JW
    Arq Neuropsiquiatr; 1996 Mar; 54(1):47-9. PubMed ID: 8736144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Lamotrigine-associated rash.
    Hirsch LJ; Weintraub DB; Buchsbaum R; Spencer HT; Straka T; Hager M; Resor SR
    Epilepsia; 2006 Feb; 47(2):318-22. PubMed ID: 16499755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash.
    Ketter TA; Wang PW; Chandler RA; Alarcon AM; Becker OV; Nowakowska C; O'Keeffe CM; Schumacher MR
    J Clin Psychiatry; 2005 May; 66(5):642-5. PubMed ID: 15889953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tolerability of lamotrigine in children.
    Messenheimer JA; Giorgi L; Risner ME
    Drug Saf; 2000 Apr; 22(4):303-12. PubMed ID: 10789824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the incidence of lamotrigine-related skin rash.
    Wong IC; Mawer GE; Sander JW
    Ann Pharmacother; 1999 Oct; 33(10):1037-42. PubMed ID: 10534214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of lamotrigine.
    Richens A
    Epilepsia; 1994; 35 Suppl 5():S37-40. PubMed ID: 8039469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety review of adult clinical trial experience with lamotrigine.
    Messenheimer J; Mullens EL; Giorgi L; Young F
    Drug Saf; 1998 Apr; 18(4):281-96. PubMed ID: 9565739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamotrigine-induced rash in children.
    Dooley J; Camfield P; Gordon K; Camfield C; Wirrell Z; Smith E
    Neurology; 1996 Jan; 46(1):240-2. PubMed ID: 8559384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine-related skin rashes in adults.
    Huang CW; Tsai JJ; Lai ML
    Kaohsiung J Med Sci; 2002 Nov; 18(11):566-72. PubMed ID: 12513019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of long-term lamotrigine in epilepsy.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis.
    Wang XQ; Xiong J; Xu WH; Yu SY; Huang XS; Zhang JT; Tian CL; Huang DH; Jia WQ; Lang SY
    Seizure; 2015 Feb; 25():52-61. PubMed ID: 25645637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials.
    Bloom R; Amber KT
    An Bras Dermatol; 2017; 92(1):139-141. PubMed ID: 28225977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious rash with lamotrigine after carbamazepine discontinuation: a case report.
    Subuh Surja AA; Brotzge KE; El-Mallakh RS
    J Clin Psychiatry; 2005 Mar; 66(3):400-1. PubMed ID: 15766317
    [No Abstract]   [Full Text] [Related]  

  • 19. Rechallenge with lamotrigine after initial rash.
    Tavernor SJ; Wong IC; Newton R; Brown SW
    Seizure; 1995 Mar; 4(1):67-71. PubMed ID: 7788112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine rechallenge after a skin rash. A combined study of open cases and a meta-analysis.
    Serrani Azcurra DJ
    Rev Psiquiatr Salud Ment; 2013; 6(4):144-9. PubMed ID: 23084805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.